病毒性肝炎
医学
肝炎
乙型肝炎
丙型肝炎
公共卫生
丙型肝炎病毒
免疫学
病毒学
甲肝
病毒
病理
作者
Andrea L. Cox,Manal H. El‐Sayed,Jia‐Horng Kao,Jeffrey V. Lazarus,Maud Lemoine,Anna S. Lok,Fabien Zoulim
标识
DOI:10.1038/s41575-020-0332-6
摘要
The global burden of viral hepatitis is substantial; in terms of mortality, hepatitis B virus and hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top four global infectious diseases. In 2016, the 194 Member States of the World Health Organization committed to eliminating viral hepatitis as a public health threat by 2030, with a particular focus on hepatitis B virus and hepatitis C virus infection. With only 10 years to go until the 2030 deadline is reached, and although much progress has been made towards elimination, there are still some important gaps in terms of policy and progress. In this Viewpoint, we asked a selection of scientists and clinicians working in the viral hepatitis field for their opinions on whether elimination of viral hepatitis by 2030 is feasible, what the key areas of progress are and what the focus for the next 10 years and beyond should be for viral hepatitis elimination.
科研通智能强力驱动
Strongly Powered by AbleSci AI